Search

everythinglearnresearchcommunity

for

Search:↓

John Cazale's hairline showed strong recession at the temples but maintained solid volume and density, sparking discussion on different hair loss patterns and the importance of overall hair density. Treatments like Minoxidil and Spironolactone were mentioned as potential factors in maintaining hair, though genetics and styling were also considered significant.

A user expressed concern about using low-dose topical finasteride while conceiving, but was reassured that the risk of affecting a fetus is negligible. The user stopped using finasteride during pregnancy and switched to minoxidil and ketoconazole, while others shared experiences and advice on using these treatments safely.

Pelage is moving to Phase III clinical trials for PP405, a hair loss treatment, with results to be presented at a medical meeting. Users express skepticism and hope, comparing it to existing treatments like Minoxidil and finasteride, while discussing the potential for new hair growth in previously bald areas.

The conversation is about a user's 6-month progress using topical Minoxidil (5%) and oral Finasteride (2.5 mg) for hair loss, emphasizing consistency for results. The user reports some side effects like mental fog and increased body hair but no significant changes in libido.

Hairlines and hair loss treatments like finasteride and hair transplants. Celebrities' hairlines are discussed, noting genetics and interventions.

The user experienced significant hair regrowth in 90 days using 1.25 mg finasteride daily and topical 5% minoxidil once a day, with noticeable thickening of eyebrows and eyelashes. Despite the progress, the user plans a hair transplant due to traction alopecia affecting the hairline.

The user humorously describes trying various hair loss treatments, including minoxidil, finasteride, and RU58841, with a satirical twist involving psychedelic experiences and imaginary entities. They mistakenly used LSD instead of RU58841 and plan to continue experimenting with other substances.

People are hopeful about future hair loss treatments like PP405, GT20029, and VDPHL01, while some are currently using finasteride and minoxidil. There is skepticism about the effectiveness of new treatments, and some advise against hair transplants until more promising drugs are available.

CRISPR Cas9 could potentially treat baldness by targeting specific genes in hair follicles without affecting other body functions. There is optimism about its future use, despite ethical concerns and the current reliance on treatments like minoxidil and finasteride.

The user successfully managed hair regrowth by using a combination of finasteride, dutasteride, minoxidil, and specific shampoos to treat seborrheic dermatitis. They emphasize the importance of maintaining a healthy scalp and are considering food intolerance tests to further address inflammation.

The user experienced significant hair regrowth over two months using a regimen of daily minoxidil, daily finasteride, and weekly microneedling. They reported no major side effects, except for temporary watery loads, and emphasized the importance of consistency.

The user experienced temple recession, shedding, and acne while on 0.5mg dutasteride, 1.25mg finasteride every other day, and 5mg oral minoxidil daily. They are considering switching treatments due to worsening symptoms and are contemplating using a topical anti-androgen like RU58841.

The user experienced positive results with topical Minoxidil 6%, Finasteride 0.3%, and Tretinoin 0.025% over two months, with improved hair density and no significant side effects except for a dry, itchy scalp. The user uses a biotin shampoo and conditioner to manage scalp issues and applies the treatment once daily.

The user has scheduled a hair transplant after stabilizing hair loss with finasteride and minoxidil, considering additional dermarolling. They are advised to use 2500-3000 grafts conservatively for temple filling without lowering the hairline too much.

Finasteride improved hair thickness for someone with diffused thinning after 11 months, with no side effects. Patience and consulting a dermatologist are advised, and minoxidil is suggested for additional support.

The user is experiencing ongoing hair shedding despite using oral minoxidil, topical and oral finasteride, magnesium, and vitamin D3. They are advised to stick with oral finasteride and topical minoxidil for a year, as frequent changes might affect results, and are reassured about future hair cloning advancements.

A user shared their progress in hair regrowth after 3 months using Minoxidil, Finasteride, Biotin, and dermarolling, feeling confident enough to go outside without a hat for the first time in 2 years. The conversation includes questions about side effects, dermarolling, and hair care products.

PP405 is a promising molecule that may reactivate dormant hair follicles, potentially offering a new treatment for hair loss. It is in phase 2 trials, with possible availability between 2027 and 2030.

Maintaining good hair density is more important than preventing a receding hairline, as it can enhance a mature look. Treatments discussed include finasteride, minoxidil, dutasteride, and RU58841.

The conversation discusses the delay in the PP405 Phase 2 study results, now expected by the end of 2025, and skepticism about research practices. There is also mention of optimism for Amplifica's AMP303 and a topical treatment in early testing.

A user experienced worsening hair recession after adding 0.5 mg daily dutasteride to their regimen of topical minoxidil and finasteride, despite no initial shedding. They plan to continue monitoring the situation, as others suggest it may be too early to see results and recommend blood tests to check DHT levels.

The user experienced worsening hair density after using finasteride, dutasteride, and RU58841, suspecting RU58841 might be the cause. They are considering stopping RU58841 after a scalp biopsy, while others share mixed experiences with RU58841's effectiveness.

The conversation discusses various hair loss treatments, including minoxidil, finasteride, dutasteride, RU58841, microneedling, ketoconazole shampoo, and laser therapy. Users emphasize the importance of consistency, patience, and individual response to treatments.

The user experienced hair regrowth after 7 months of using finasteride, minoxidil, and ketoconazole shampoo, with shedding stopping recently. They reported no side effects and use a minimal oral dose of minoxidil.

The user has been using oral dutasteride 0.5mg, oral minoxidil 2mg, and topical minoxidil 5% for hair regrowth, along with microneedling. They have seen significant hair coverage improvement and are considering additional supplements for better results.

Applying Minoxidil takes users between 10 seconds to 20 minutes, with most finding quicker methods more efficient. Techniques vary from using foam, liquid, or spray, with some users recommending buzz cuts for easier application.

The conversation discusses the use of RU58841 for hair loss, focusing on its side effects, standardization issues, and user experiences. The user also inquires about the use of other treatments like minoxidil, finasteride, and microneedling.

A 28-year-old male experienced significant hair regrowth over 8 months using 1.25mg of finasteride daily, without minoxidil or micro needling. He also took vitamin D3, K2, magnesium, and a B100 complex, reporting increased libido as a side effect.

People over 35 have seen success with finasteride, minoxidil, and dutasteride for hair loss. Results vary, with some noticing improvements in hair volume and hairline, while others emphasize patience and managing expectations.

A user shared progress pictures after 3 months of using Minoxidil and dermastamping, noting additional biotin use. Replies suggest adding finasteride to maintain results and highlight effective regrowth from microneedling and Minoxidil.